Figure 7b plots enrichment results over KEGG pathways for downregulated genes, where interleukin 17 (IL17) signaling pathway, rheumatoid arthritis, lipid and atherosclerosis, and central carbon metabolism in cancer can be seen as examples of supressed pathways [58–60]. This evidence concerns the gene IL17A and atherosclerosis.